NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PolarityTE Inc (F: NJTC)

 
NJTC Technical Analysis
5
As on 16th May 2022 NJTC STOCK Price closed @ 0.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.78 & Strong Sell for SHORT-TERM with Stoploss of 0.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NJTCSTOCK Price

Open 0.17 Change Price %
High 0.17 1 Day -0.08 -32.00
Low 0.17 1 Week 0.02 13.33
Close 0.17 1 Month -0.07 -29.17
Volume N/A 1 Year -0.37 -68.52
52 Week High 1.51 | 52 Week Low 0.10
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
NJTC
Daily Charts
NJTC
Intraday Charts
Whats New @
Bazaartrend
NJTC
Free Analysis
 
NJTC Important Levels Intraday
RESISTANCE0.17
RESISTANCE0.17
RESISTANCE0.17
RESISTANCE0.17
RESISTANCE0.17
RESISTANCE0.17
RESISTANCE0.17
RESISTANCE0.17
 
NJTC Forecast May 2024
4th UP Forecast2.19
3rd UP Forecast1.54
2nd UP Forecast1.14
1st UP Forecast0.74
1st DOWN Forecast-0.4
2nd DOWN Forecast-0.8
3rd DOWN Forecast-1.2
4th DOWN Forecast-1.85
 
NJTC Weekly Forecast
4th UP Forecast0.25
3rd UP Forecast0.22
2nd UP Forecast0.21
1st UP Forecast0.19
1st DOWN Forecast0.15
2nd DOWN Forecast0.13
3rd DOWN Forecast0.12
4th DOWN Forecast0.09
 
NJTC Forecast2024
4th UP Forecast2.94
3rd UP Forecast2.05
2nd UP Forecast1.5
1st UP Forecast0.95
1st DOWN Forecast-0.61
2nd DOWN Forecast-1.16
3rd DOWN Forecast-1.71
4th DOWN Forecast-2.6
 
 
NJTC Other Details
Segment EQ
Market Capital 41894084.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NJTC Address
NJTC
 
NJTC Latest News
 
Your Comments and Response on PolarityTE Inc
 
NJTC Business Profile
PolarityTE, Inc., a biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates through two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and OsteoTE. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah. Address: 1960 South 4250 West, Salt Lake City, UT, United States, 84104
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service